Denosumab-bmwo Injection
Product Images NDC 72606-059

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Denosumab-bmwo (NDC 72606-059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celltrion Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Denosumab Bmwo 01)

The text provides data for Calcium (Corrected) levels in mmol/L and mg/dL for a study involving Denosumab. The corrected Calcium levels are listed at different time points during the study, ranging from 4.0 to 20 mmol/L. The Denosumab treatment group with 23 participants shows their corresponding Calcium levels throughout the study days, starting from BL (Baseline) to Day 57. The values for Calcium in mg/dL are also provided at the end of the text.*

FDA Label Image

Principal Display Panel (120 mg/1.7 mL Vial Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.